EHRA Premium Access

Quality of life and 12-month efficacy outcomes in paroxysmal and persistent af following pvi using the pvac gold ablation catheter: results from the multicenter GOLD AF registry

Topic: Rhythm Control, Catheter Ablation

Congress Presentation

About the speaker

Professor Lucas Boersma

St Antonius Hospital, Nieuwegein (Netherlands (The))
39 presentations
4 followers

10 more presentations in this session

A randomized clinical trial of cryoballoon vs. irrigated radiofrequency catheter ablation for atrial fibrillation:The CIRCA-DOSE Study

Speaker: Doctor J. Andrade (Vancouver, CA)

Thumbnail

CIRCA-DOSE Study - Discussion

Speaker: Professor D. Scherr (Graz, AT)

Thumbnail

Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation - AVATAR AF

Speaker: Professor P. Kanagaratnam (London, GB)

Thumbnail

Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation - Discussion

Speaker: Professor J. Merino (Madrid, ES)

Thumbnail

GOLD AF registry - Discussion

Thumbnail

Access the full session

Late-breaking trials 1

Speakers: Professor L. Boersma, Doctor J. Andrade, Professor D. Scherr, Professor P. Kanagaratnam, Professor J. Merino
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb